Skip to content

BillionToOne, Inc. BLLN Total Operating Expenses

Total Operating Expenses at other companies

Illumina logo
IlluminaILMN
$512M-1.3%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$48.77M+1.8%
Erasca, Inc. logo
Erasca, Inc.ERAS
$187.91M+427%
Nuvalent, Inc. logo
Nuvalent, Inc.NUVL
$119.41M+25.9%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$195.21M+192%
TEC
Bio-TechneTECH
$132.79M-24.5%

Other financials

Income statement

See full
Revenue$108.4M+83.8%
Gross profit$79.1M+108%
Operating income$17.8M+870%
Net income$18.0M+551%
EPS (diluted)$0.34+187%

Balance sheet

See full
Cash & equivalents$537.5M+181%
Total debt$144.2M
Total equity$505.6M+300%
Total assets$700.7M

Cash flow

See full
Operating cash flow$15.4M+488%
CapEx$4.5M+90.5%
Free cash flow$11.0M+3,842%

Valuation

See full
Market cap$4.84B

Profitability

See full
Gross margin70.4%
Operating margin-96.9%
Net margin8.4%
FCF margin-83.4%

Returns & leverage

See full
Debt / equity0.3×
Current ratio10.9×

Where this comes from

Reported directly by BillionToOne, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: BillionToOne, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BillionToOne, Inc. 's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BillionToOne, Inc. 's total operating expenses?
BillionToOne, Inc. (BLLN) reported total operating expenses of $61.26M in Q1 2026.
How has BillionToOne, Inc. 's total operating expenses changed year-over-year?
BillionToOne, Inc. 's total operating expenses increased by 52.1% year-over-year, from $40.29M to $61.26M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.